Intrathecal betamethasone for cancer pain

[Olga]

New pain treatment option is described by the team from Japan that might help to cancer patients with opioid‐resistant cancer pain

Intrathecal betamethasone for cancer pain: A study of its analgesic efficacy and safety
https://www.onlinelibrary.wiley.com/doi ... /aas.13305

Intrathecal injection of betamethasone once a week may be an optimal option for producing long‐lasting analgesia and improving activities of daily living in patients with intractable cancer pain, especially that caused by vertebral and nerve plexus metastases. ITB‐induced analgesia may be closely related to induction of apoptosis of cancer cells, resulting in a therapeutic attack on the cancer pathology; further detailed studies are necessary to confirm these findings.